Table 1.
Patient demographics (N = 714).
| Age (years) | 52.2 (±12.0) |
| <50 | 278 (38.9%) |
| ≥50 | 436 (61.1%) |
| Year | |
| 2004 | 143 (20.0%) |
| 2005 | 155 (21.7%) |
| 2006 | 153 (21.4%) |
| 2007 | 143 (20.0%) |
| 2008 | 120 (16.8%) |
| Histology | |
| SCC | 487 (68.2%) |
| Adeno | 149 (20.9%) |
| AS | 63 (8.8%) |
| Others | 15 (2.1%) |
| Tumor size | |
| ≤2 cm | 31 (4.3%) |
| 2.1 –4.0 cm | 321 (45.0%) |
| 4.1 –6.0 cm | 275 (38.5%) |
| >6.0 cm | 61 (8.5%) |
| Missing | 26 (3.6%) |
| Parametrial involvement | |
| No | 314 (44.0%) |
| Yes | 400 (56.0%) |
| DSI | |
| Not involved | 116 (16.2%) |
| Involved | 540 (75.6%) |
| Missing | 58 (8.1%) |
| LVSI | |
| No | 138 (19.3%) |
| Yes | 533 (74.6%) |
| Missing | 43 (6.0%) |
| Uterine corpus | |
| Not involved | 510 (71.4%) |
| Involved | 191 (26.8%) |
| Missing | 13 (1.8%) |
| Ovarian metastasis | |
| No | 681 (95.4%) |
| Yes | 21 (2.9%) |
| Missing | 12 (1.7%) |
| Pelvic lymph node | |
| Not involved | 359 (50.3%) |
| Single metastasis | 120 (16.8%) |
| Multiple metastasis | 224 (31.4%) |
| Missing | 11 (1.5%) |
| Para-aortic lymph node | |
| Not involved | 141 (19.7%) |
| Single metastasis | 15 (2.1%) |
| Multiple metastasis | 27 (3.8%) |
| Clinically not involved | 531 (74.4%) |
| Peritoneal cytology | |
| No malignancy | 327 (45.8%) |
| Malignant cells | 39 (5.5%) |
| Not performed | 346 (48.5%) |
| Missing | 2 (0.3%) |
| Adjuvant therapy | |
| CCRT | 256 (35.9%) |
| RT alone | 198 (27.7%) |
| Chemotherapy alone | 132 (18.5%) |
| RT/chemotherapy | 21 (2.9%) |
| None | 78 (10.9%) |
| Missing | 29 (4.1%) |
Mean (±SD) or number (%) per column are shown. Abbreviations: SCC, squamous cell carcinoma; Adeno, adenocarcinoma; AS, adenosquamous; DSI, deep stromal invasion; LVSI, lympho-vascular space invasion; CCRT, concurrent chemoradiotherapy; and RT, radiotherapy.